OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 584-592.e1
Open Access | Times Cited: 85
Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 584-592.e1
Open Access | Times Cited: 85
Showing 26-50 of 85 citing articles:
Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis
Seth S. Jeong, Tiffany Chen, Shaun A. Nguyen, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 21
Seth S. Jeong, Tiffany Chen, Shaun A. Nguyen, et al.
Rhinology Journal (2022)
Open Access | Times Cited: 21
Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
Joaquim Mullol, Miguel J. Maldonado, José A. García del Castillo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2438-2447.e9
Closed Access | Times Cited: 21
Joaquim Mullol, Miguel J. Maldonado, José A. García del Castillo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2438-2447.e9
Closed Access | Times Cited: 21
Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
Shunsuke Minagawa, Jun Araya, Naoaki Watanabe, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Shunsuke Minagawa, Jun Araya, Naoaki Watanabe, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
Sven Schneider, Katharina Poglitsch, Christina Morgenstern, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201335-2201335
Open Access | Times Cited: 21
Sven Schneider, Katharina Poglitsch, Christina Morgenstern, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201335-2201335
Open Access | Times Cited: 21
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
The value of biomarkers in the therapy of CRSwNP with biologicals—a long-term follow-up of dupilumab therapy
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Sven Ole Sarnoch, Amra Pepić, Lisa Schmitz, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 9, pp. 4789-4805
Open Access | Times Cited: 4
Real‐world predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps
Christina Dorismond, Mason R. Krysinski, Yash Trivedi, et al.
International Forum of Allergy & Rhinology (2024)
Open Access | Times Cited: 4
Christina Dorismond, Mason R. Krysinski, Yash Trivedi, et al.
International Forum of Allergy & Rhinology (2024)
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Proposal of a New Composite Score (DAMADECO) to Simultaneously Evaluate Asthma and CRSwNP Severity in Comorbid Patients
Maria D’Amato, Patrizio Pasqualetti, Elena Cantone, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 957-957
Open Access
Maria D’Amato, Patrizio Pasqualetti, Elena Cantone, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 957-957
Open Access
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: A systematic review and meta-analysis
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Linger Sim, Norasnieda Md Shukri, Najib Majdi Yaacob, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif‐Askari, Narjes Saheb Sharif‐Askari, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Closed Access
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps
Anju T. Peters, Xiaohui Zhao, Aimee M. Near, et al.
Advances in Therapy (2025)
Open Access
Anju T. Peters, Xiaohui Zhao, Aimee M. Near, et al.
Advances in Therapy (2025)
Open Access
Asthma Phenotypes and Biomarkers
Jocelyn R. Grunwell, Anne M. Fitzpatrick
Respiratory Care (2025)
Closed Access
Jocelyn R. Grunwell, Anne M. Fitzpatrick
Respiratory Care (2025)
Closed Access
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design
Lucía De Prado Gómez, Asif Khan, Anju T. Peters, et al.
American Journal of Rhinology and Allergy (2022) Vol. 36, Iss. 6, pp. 788-795
Closed Access | Times Cited: 16
Lucía De Prado Gómez, Asif Khan, Anju T. Peters, et al.
American Journal of Rhinology and Allergy (2022) Vol. 36, Iss. 6, pp. 788-795
Closed Access | Times Cited: 16
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
William W. Busse, Ian Pavord, Shahid Siddiqui, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 411-419
Open Access | Times Cited: 10
William W. Busse, Ian Pavord, Shahid Siddiqui, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 411-419
Open Access | Times Cited: 10
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Javier Domínguez‐Ortega, Joaquim Mullol, Francisco Javier Álvarez Gutiérrez, et al.
Journal of Allergy and Clinical Immunology Global (2023) Vol. 3, Iss. 1, pp. 100174-100174
Open Access | Times Cited: 10
Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Tomoko Tajiri, Motohiko Suzuki, Hirono Nishiyama, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 550-558.e2
Closed Access | Times Cited: 3
Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
Mona Al‐Ahmad, Asmaa Ali, Mustafa Ali Khalaf, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Mona Al‐Ahmad, Asmaa Ali, Mustafa Ali Khalaf, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
Claire Hopkins, Kathleen M. Buchheit, Enrico Heffler, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 767-773
Open Access | Times Cited: 13
Claire Hopkins, Kathleen M. Buchheit, Enrico Heffler, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 767-773
Open Access | Times Cited: 13
Current evaluation and management of patients with chronic rhinosinusitis and nasal polyps
Juan Carlos Ceballos Cantu, Isam Alobid, Joaquim Mullol
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 12, pp. 1253-1263
Closed Access | Times Cited: 13
Juan Carlos Ceballos Cantu, Isam Alobid, Joaquim Mullol
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 12, pp. 1253-1263
Closed Access | Times Cited: 13
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Advances in chronic rhinosinusitis in 2020 and 2021
Zhaofeng Xu, Yanran Huang, Tim Delemarre, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 854-866
Open Access | Times Cited: 17
Zhaofeng Xu, Yanran Huang, Tim Delemarre, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 854-866
Open Access | Times Cited: 17
Clinical Assessment of Chronic Rhinosinusitis
Claire Hopkins, Stella E. Lee, Ludger Klimek, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1406-1416
Closed Access | Times Cited: 12
Claire Hopkins, Stella E. Lee, Ludger Klimek, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1406-1416
Closed Access | Times Cited: 12
Dupilumab and tezepelumab in severe refractory asthma: new opportunities
Beatrice Ragnoli, Jaymin B. Morjaria, Patrizia Pignatti, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232210973-204062232210973
Open Access | Times Cited: 12
Beatrice Ragnoli, Jaymin B. Morjaria, Patrizia Pignatti, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232210973-204062232210973
Open Access | Times Cited: 12
Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
